What is POEMS syndrome

TL;DR: POEMS syndrome is a rare, multisystem paraneoplastic disorder caused by an underlying plasma cell neoplasm that leads to severe nerve damage and various systemic symptoms. The name is an acronym representing its five primary features: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, and Skin changes.

What exactly is POEMS syndrome?

POEMS syndrome is a complex and serious medical condition that arises from the body’s abnormal production of plasma cells. These cells produce a specific type of protein (a monoclonal protein) that triggers a cascade of inflammation and systemic damage. Because it affects multiple organ systems simultaneously, patients often see many different specialists before receiving a final diagnosis. Within our community at DiseaseMaps.org, 59 people with POEMS syndrome have joined to share their experiences, highlighting the importance of early recognition and specialized care.

Which body systems does POEMS syndrome affect?

The hallmark of POEMS syndrome is the wide range of symptoms it produces. The acronym helps clinicians remember the primary clinical features:

• P (Polyneuropathy): Progressive, often painful nerve damage starting in the feet and legs, leading to weakness and numbness.


• O (Organomegaly): Enlargement of organs, most commonly the liver, spleen, or lymph nodes.


• E (Endocrinopathy): Hormonal imbalances affecting glands like the thyroid, adrenal, or pituitary, often causing issues like diabetes or low libido.


• M (Monoclonal protein): The presence of a specific protein (usually IgA or IgG lambda) in the blood, identified through specialized testing.


• S (Skin changes): Visible symptoms such as darkening of the skin (hyperpigmentation), excessive hair growth (hypertrichosis), or small red spots (hemangiomas).

How rare is POEMS syndrome and who is affected?

POEMS syndrome is exceptionally rare, with an estimated prevalence of less than 1 in 100,000 people. It is most frequently diagnosed in middle-aged adults, typically between the ages of 50 and 60, though it can occur at any age. While both men and women can develop the condition, data suggests it is slightly more common in men. There are no known geographic, racial, or ethnic predispositions, and the disease is not considered hereditary.

How does it differ from other conditions?

Unlike many other blood-related disorders, POEMS syndrome is characterized by the presence of a specific underlying plasma cell disorder that is usually not as aggressive as multiple myeloma. A key differentiator is the severity of the polyneuropathy, which is often the most debilitating aspect of the disease. Furthermore, the presence of specific skin manifestations and organ enlargement helps clinicians distinguish this from other monoclonal gammopathies.

Next steps

• Consult a specialist: Seek evaluation from a hematologist-oncologist who has specific experience treating POEMS syndrome or rare plasma cell dyscrasias.


• Request specific tests: Ensure your medical team conducts a serum protein electrophoresis (SPEP) and immunofixation to identify the monoclonal protein.


• Join a support group: Connect with others at DiseaseMaps.org to share experiences and coping strategies for living with this complex condition.


• Monitor symptoms: Keep a detailed log of new symptoms, particularly nerve-related pain or changes in skin, to share with your care team.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): POEMS syndrome overview


• Orphanet: Rare disease database for POEMS syndrome


• OMIM (Online Mendelian Inheritance in Man): POEMS syndrome clinical entry